Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval
Over the last three decades, polymeric micelles have emerged as a highly promising drug
delivery platform for therapeutic compounds. Particularly, poorly soluble small molecules …
delivery platform for therapeutic compounds. Particularly, poorly soluble small molecules …
PEG-PCL-based nanomedicines: A biodegradable drug delivery system and its application
P Grossen, D Witzigmann, S Sieber… - Journal of Controlled …, 2017 - Elsevier
The lack of efficient therapeutic options for many severe disorders including cancer spurs
demand for improved drug delivery technologies. Nanoscale drug delivery systems based …
demand for improved drug delivery technologies. Nanoscale drug delivery systems based …
Current trends and future perspectives of bone substitute materials–from space holders to innovative biomaterials
A Kolk, J Handschel, W Drescher, D Rothamel… - Journal of Cranio …, 2012 - Elsevier
An autologous bone graft is still the ideal material for the repair of craniofacial defects, but its
availability is limited and harvesting can be associated with complications. Bone …
availability is limited and harvesting can be associated with complications. Bone …
Challenges and advances in computational docking: 2009 in review
E Yuriev, M Agostino… - Journal of Molecular …, 2011 - Wiley Online Library
Docking is a computational technique that places a small molecule (ligand) in the binding
site of its macromolecular target (receptor) and estimates its binding affinity. This review …
site of its macromolecular target (receptor) and estimates its binding affinity. This review …
Curcumin nanomedicine: a road to cancer therapeutics
M M. Yallapu, M Jaggi… - Current pharmaceutical …, 2013 - benthamdirect.com
Cancer is the second leading cause of death in the United States. Conventional therapies
cause widespread systemic toxicity and lead to serious side effects which prohibit their long …
cause widespread systemic toxicity and lead to serious side effects which prohibit their long …
Polymer–drug conjugates: Recent advances and future perspectives
P Thakor, V Bhavana, R Sharma, S Srivastava… - Drug Discovery …, 2020 - Elsevier
Highlights•PDC a promising strategy to improve solubilization and drug targeting.•Natural
and synthetic polymers as building blocks of PDC.•Polymer and polysaccharide using graft …
and synthetic polymers as building blocks of PDC.•Polymer and polysaccharide using graft …
Polymer-drug conjugates: Design principles, emerging synthetic strategies and clinical overview
Adagen, an enzyme replacement treatment for adenosine deaminase deficiency, was the
first protein-polymer conjugate to be approved in early 1990 s. Post this regulatory approval …
first protein-polymer conjugate to be approved in early 1990 s. Post this regulatory approval …
A drug-specific nanocarrier design for efficient anticancer therapy
The drug-loading properties of nanocarriers depend on the chemical structures and
properties of their building blocks. Here we customize telodendrimers (linear dendritic …
properties of their building blocks. Here we customize telodendrimers (linear dendritic …
Computational modeling for the design and development of nano based drug delivery systems
The nanoparticle delivery system is one of the promising nanotechnology applications for
efficient drug delivery to the targeted site. However, the selection of lead excipient …
efficient drug delivery to the targeted site. However, the selection of lead excipient …
Advances in oral controlled drug delivery: the role of drug–polymer and interpolymer non-covalent interactions
S De Robertis, MC Bonferoni, L Elviri… - Expert opinion on …, 2015 - Taylor & Francis
Introduction: After more than four decades of intense research, oral controlled drug delivery
systems (DDSs) still represent a topic of major interest for pharmaceutical scientist and …
systems (DDSs) still represent a topic of major interest for pharmaceutical scientist and …